Jurors set to hear closing arguments as prosecutors paint Martin Shkreli as compulsive liar
As prosecutors get ready to wrap up at the trial for “Pharma Bro” Martin Shkreli, they have painted the picture of a compulsive liar who relied on a Ponzi-like scheme to make up for his bad investments.
Shkreli, 34, became infamous prior to the start of his trial for grossly marking up the price of HIV/AIDS medication that his pharmaceutical company purchased, and for purchasing the rights to, but not releasing, the Wu-Tang Clan album “Once Upon a Time in Shaolin” in 2015.
Shkreli isn’t on trial for upping drug prices or hoarding rap music, instead the government has charged him with securities fraud related to a pair of hedge funds he ran.